tiprankstipranks
Trending News
More News >
Standard Biotools Inc (LAB)
NASDAQ:LAB
US Market

Standard BioTools (LAB) Income Statement

Compare
471 Followers

Standard BioTools Income Statement

Last quarter (Q4 2025), Standard BioTools's total revenue was $3.22M, a decrease of -93.10% from the same quarter last year. In Q4, Standard BioTools's net income was $19.28M. See Standard BioTools’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 85.33M$ 174.43M$ 106.34M$ 97.95M$ 130.58M
Gross Profit
$ 42.54M$ 84.26M$ 50.45M$ 37.05M$ 69.37M
Operating Expenses
$ 135.85M$ 259.50M$ 127.05M$ 153.26M$ 136.83M
Depreciation and Amortization
$ 1.72M$ 16.86M$ 15.18M$ 15.03M$ 15.57M
EBITDA
$ -94.96M$ -118.14M$ -54.46M$ -173.57M$ -44.27M
Operating Income
$ -93.31M$ -175.24M$ -76.60M$ -116.20M$ -67.46M
Other Income/Expenses
$ -3.40M$ 36.92M$ 2.40M$ -76.72M$ 3.80M
Pretax Income
$ -96.70M$ -138.31M$ -74.20M$ -192.93M$ -63.66M
Net Income
$ -74.90M$ -138.88M$ -74.66M$ -190.10M$ -59.24M
Per Share Metrics
Basic EPS
$ -0.20$ -0.52$ -0.94$ -2.43$ -0.78
Diluted EPS
$ -0.20$ -0.52$ -0.94$ -2.43$ -0.78
Weighted Average Shares Outstanding
381.62M 352.67M 79.16M 78.31M 75.79M
Weighted Average Shares Outstanding (Diluted)
381.62M 352.67M 79.16M 78.31M 75.79M
Currency in USD

Standard BioTools Earnings and Revenue History